Mark Benadiba and Ben Knight Join Tinley’s Advisory Board

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
51
Mark Benadiba and Ben Knight Join Tinley’s Advisory Board

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. PERSONS

SANTA MONICA, Calif. and TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “ Company " or " Tinley ") (CSE:TNY) (OTCQX:TNYBF) is pleased to announce that long-time Cott Board and Executive member Mark Benadiba, and California cannabis industry leader Ben Knight have joined the Company’s advisory board.

Mark Benadiba served as a Director of Cott Corporation from June 2008 through December 2017, having actively collaborated with his board colleagues to oversee over US$2 billion in market growth, as well as drive the company’s transition from traditional carbonated soft drinks to healthier, higher-growth beverage categories.  Prior to joining Cott’s board, Mr. Benadiba served in various executive roles including CEO and Executive Vice-President of Cott Canada from 1990 through 2006, and Executive Vice President, USA Operations from 1996 until 2006.  As a key Cott executive serving working closely with its founders over the years of Cott’s explosive growth, Mr. Benadiba and his team helped guide the business and drive the building of efficient capacity, through a strategy of excellence in own-plant operations, contract packing, and regional partnerships and beverage acquisitions.  During his tenure, Cott disrupted the largest category in grocery to become the world’s third-largest beverage company after Coca-Cola and Pepsi.  Prior to Cott, Mr. Benadiba was a Senior Executive of Pepsi/Seven-Up Canada (a division of Seven-Up Canada Inc.), and a member of its ownership group.

Ben Knight serves as Chief Operating Officer and Chief Financial Officer of Purple Mountain Holdings, a California-based cannabis-focused holding and investment company.  He is also Chief Operating Officer of CMX Distribution, the first cannabis distributor to become licensed in a major urban center in Southern California.  He also oversees 420 Central Brand Stores, which operates one of Southern California’s largest cannabis dispensaries and is working to expand its store outlets throughout the State.  Before partnering and founding businesses across retail, manufacturing and distribution in the cannabis industry, Mr. Knight held leadership roles in both mid-market and enterprise organizations.  Most recently, Knight was a Director of Microsoft’s Enterprise Group. In this role he was responsible for the corporate transformation to the cloud infrastructure and services business, which outperformed the market and took share from competition. Previously, Knight led Sales for the Microsoft Business Division. Before joining Microsoft, Knight was a Director of a leading technology services provider to Fortune 500 organizations across the United States and Europe.  Mr. Knight has also served in advisory positions for non-profits focused on youth in technology and local community development.

“Mark Benadiba’s leadership, especially in driving Cott’s co-packing business, enriches the existing Tinley team’s track record at Cott of creating comprehensive beverage formulations and merchandising programs for own brands and other national brand clients.  This supports Tinley’s business model of own-brand and contract development and production excellence in the emerging cannabis beverage industry,” said Jeff Maser, CEO of Tinley.

“At the same time, we look forward to leveraging Ben Knight’s pioneering California cannabis industry expertise and Fortune 500 experience to adapt our best practices from the mainstream beverage industry for cannabis product development, distribution and retailing,” continued Maser.   

About The Tinley Beverage Company and Hemplify

The Tinley Beverage Company (Toronto, Canada) manufactures a line of liquor-inspired, alcohol-free, cannabis-infused beverages for use in California.  Tinley also manufactures the "Hemplify®" and “Tinley TM Tonics” line of hemp extract CBD products, which are available in retail locations in California and online throughout the United States.    

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and the other risks involved in the mineral exploration and development industry. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

Products and formulations outlined herein are subject to change at anytime.

For further information on The Tinley Beverage Company, please contact:

The Tinley Beverage Company Inc. Jeff Maser, Chief Executive Officer          77 King Street West, Suite 2905 Toronto, Ontario  Canada  M5K 1H1 (310) 507-9146 Twitter:  @drinkhemplify Instagram:  @hemplify www.drinktinley.com CSE:TNY  OTCQX:TNYBF (formerly OTC:QRSRF)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

HALiXPEDITE Revolutionizes Biologics Therapy Development Process

Updated Category News Views 147

HALiXPEDITE: Transforming the Future of Biologics Development HALIX, a prominent global healthcare Contract Development and Manufacturing Organization (CDMO), recently unveiled its innovative platform, HALiXPEDITE, at a notable conference. This platform is specifically designed to expedite the development of biologics therapies, focusing on a streamlined approach to...

Continue Reading
Day One Biopharmaceuticals to Share Q3 2025 Insights

Updated Category News Views 170

Day One Biopharmaceuticals to Present Q3 2025 Financial Results In a busy season for the biopharmaceutical industry, Day One Biopharmaceuticals (Nasdaq: DAWN) has announced it will host a live conference call and webcast aimed at reporting its financial results and outlining corporate progress for the third quarter of 2025. Conference Call Details The event is scheduled...

Continue Reading
Leica Biosystems Promotes DICOM Standards for Digital Pathology

Updated Category News Views 114

Leica Biosystems Promotes DICOM Standards for Digital Pathology Leica Biosystems, a prominent figure in anatomic pathology, has recently made waves in the medical field with a bold new initiative. By announcing the non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, they aim to boost the implementation of...

Continue Reading
LYNPARZA: A Breakthrough in Early Breast Cancer Treatments

Updated Category News Views 288

Significant Survival Benefits with LYNPARZA in Breast Cancer Recent findings from the OlympiA Phase III trial bring exciting news for patients battling early breast cancer. AstraZeneca and Merck & Co., Inc.'s LYNPARZA (olaparib) has showcased profound improvements in survival rates among patients with germline BRCA-mutated HER2-negative high-risk early breast cancer. This...

Continue Reading
EuroDry Limited's Stock Experiences Volatility Amid Challenges

Updated Category News Views 229

EuroDry Limited Faces Stock Turmoil EuroDry Ltd. (NASDAQ: EDRY), a leading provider in drybulk shipping, has recently encountered a tumultuous phase, with its stock reaching a noteworthy low at $14.1. This decline marks a significant reflection on the year's challenges the company has faced, indicated by a -14.71% change over the past year. Market Conditions and...

Continue Reading